Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN1 | P18031 | 9/20 | 0.83 |
| ▸ | ALOX5 | P09917 | 2/20 | 0.70 |
| ▸ | F3 | P13726 | 4/20 | 0.65 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.65 |
| ▸ | USP2 | O75604 | 1/20 | 0.65 |
| ▸ | LMNA | P02545 | 1/20 | 0.65 |
| ▸ | USP7 | Q93009 | 1/20 | 0.65 |
| ▸ | SLCO1B3 | Q9NPD5 | 1/20 | 0.65 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 0.65 |
| ▸ | TOP2A | P11388 | 1/20 | 0.61 |
| ▸ | AKR1B10 | O60218 | 1/20 | 0.56 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.56 |
| ▸ | CES2 | O00748 | 1/20 | 0.56 |
| ▸ | CES1 | P23141 | 1/20 | 0.56 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.53 |
| ▸ | OXTR | P30559 | 1/20 | 0.53 |
| ▸ | AVPR1A | P37288 | 1/20 | 0.53 |
| ▸ | CD81 | P60033 | 1/20 | 0.53 |
| ▸ | SIRT5 | Q9NXA8 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30893653 | 1.00 | PTPN1 (0.83) | PTPN1ALOX5F3CYP3A4USP2 | |
| SCHEMBL19284333 | 0.91 | PTPN1 (1.00) | PTPN1ALOX5F3CYP3A4USP2 | |
| SCHEMBL29934333 | 0.91 | PTPN1 (1.00) | PTPN1ALOX5F3CYP3A4USP2 | |
| SCHEMBL30222071 | 0.90 | PTPN1 (0.68) | PTPN1ALOX5F3CYP3A4USP2 | |
| SCHEMBL1050527 | 0.90 | PTPN1 (0.68) | PTPN1ALOX5F3CYP3A4USP2 | |
| SCHEMBL15132632 | 0.90 | PTPN1 (0.68) | PTPN1ALOX5F3CYP3A4USP2 | |
| SCHEMBL4324523 | 0.90 | PTPN1 (0.68) | PTPN1ALOX5F3CYP3A4USP2 | |
| SCHEMBL15883003 | 0.88 | PTPN1 (0.66) | PTPN1ALOX5F3CYP3A4USP2 | |
| SCHEMBL13559844 | 0.88 | PTPN1 (0.66) | PTPN1ALOX5F3CYP3A4USP2 | |
| Soyasapogenol B SCHEMBL398310 | 0.87 | ALOX5 (0.78) | PTPN1ALOX5F3CYP3A4USP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220291237-A1 | Gene Expression Inflammatory Age and Its Uses | Edifice Health, Inc. (US) | 2022-09-15 | — | — | US | disclosed |
| US-20180132516-A1 | POSITIVE ALLOSTERIC MODULATORS OF SWEET TASTE | SENSORYGEN INC (US) | 2018-05-17 | — | — | US | disclosed |
| US-20110020226-A1 | PARTICLE STRUCTURES COMPRISING STEROLS AND SAPONINS | NORDIC VACCINE TECHNOLOGY A/S | 2011-01-27 | — | — | US | disclosed |
| US-7713942-B2 | Cage-like microparticle complexes comprising sterols and saponins for delivery of polynucleotides | NORDIC VACCINE TECHNOLOGY A/S (DK) | 2010-05-11 | — | — | US | disclosed |
| EP-2011517-A1 | Polynucleotide binding complexes comprising sterols and saponin | Nordic Vaccine Technology A/S (DK) | 2009-01-07 | — | — | EP | disclosed |
| EP-1377320-B1 | POLYNUCLEOTIDE BINDING COMPLEXES COMPRISING STEROLS AND SAPONINS | NORDIC VACCINE TECHNOLOGY AS (DK) | 2008-10-01 | — | — | EP | disclosed |
| EP-1409009-A1 | THERAPEUTICAL VACCINATION | Nordic Vaccine Technology A/S (DK) | 2004-04-21 | — | — | EP | disclosed |
| EP-1377320-A2 | POLYNUCLEOTIDE BINDING COMPLEXES COMPRISING STEROLS AND SAPONINS | Nordic Vaccine Technology A/S (DK) | 2004-01-07 | — | — | EP | disclosed |
| WO-2002102407-A1 | THERAPEUTICAL VACCINATION | NORDIC VACCINE TECHNOLOGY A/S (DK) | 2002-12-27 | — | — | WO | disclosed |
| WO-2002080981-A2 | POLYNUCLEOTIDE BINDING COMPLEXES COMPRISING STEROLS AND SAPONINS | NORDIC VACCINE TECHNOLOGY A/S (DK) | 2002-10-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110020226-A1 | PARTICLE STRUCTURES COMPRISING STEROLS AND SAPONINS | LSS, SNRPE, HLA-C | PTPN1 2398/4885ALOX5 651/4885F3 3104/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.